SiSaf Ltd
PrivateLast Round
Series B
Nov 26, 2020
Total Funding Raised
$43.47M
Company Overview
SiSaf Ltd is a biopharmaceutical company that develops RNA therapeutics for conditions such as cancer and rare genetic skeletal disorders using its proprietary Bio-Courier® delivery platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SiSaf Ltd Comparables
Compare SiSaf Ltd with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genevant Sciences | 82% | |
| ReCode Therapeutics | 78% | |
| Acuitas Therapeutics | 78% |
SiSaf Ltd Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 26, 2020 | ||||
| Series A Extension | Aug 1, 2018 | ||||
| Series A | Sep 19, 2016 | ||||
| Seed | Oct 23, 2013 | ||||
| Seed | Apr 4, 2011 |
Key People
Founding team and executive leadership
SiSaf Ltd Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovation Ulster Limited | Seed, Series A Extension |
| Future Fund | Series B |
| Invest Northern Ireland | Series A Extension, Seed, Series A |
| Silicon Valley Global Ventures | Seed |
| Clarendon Fund Managers | Seed |
| Vickers Venture Partners | Series A Extension, Series B, Series A |
| Innovation Ulster Ltd | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 26, 2020
$13M round led by Vickers Venture Partners.
- Sep 19, 2016
$4M round led by Vickers Venture Partners.
SiSaf Ltd Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about SiSaf Ltd's valuation, stock price, and market status.
Is SiSaf Ltd a public or private company?
SiSaf Ltd is a private company.
What is the current stock price of SiSaf Ltd?
SiSaf Ltd is a private company with no public stock price. No recent secondary market data is available.
How much is SiSaf Ltd worth (valuation)?
Valuation information for SiSaf Ltd is not publicly available.
Can I buy SiSaf Ltd stock?
SiSaf Ltd shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was SiSaf Ltd's last funding round?
SiSaf Ltd's most recent funding round was Series B on November 26, 2020.
Who are the main investors in SiSaf Ltd?
Key investors in SiSaf Ltd include Silicon Valley Global Ventures, Vickers Venture Partners.
Will SiSaf Ltd IPO soon?
No public IPO plans have been announced for SiSaf Ltd.
How can I track SiSaf Ltd secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor SiSaf Ltd's secondary market activity and sign up for updates.